@article{1e0986b2175c49bd9576cb55fb84357c,
title = "Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages",
abstract = "We systematically reviewed the comparative effectiveness of injectable beta-interferons (IFN-β) and glatiramer acetate (GA) on annualised relapse rate (ARR), progression and discontinuation due to adverse events (AEs) in RRMS, using evidence from within the drugs{\textquoteright} recommended dosages.",
keywords = "multiple sclerosis, clinically isolated syndrome, beta-interferon, glatiramer acetate, systematic review, economic evaluation",
author = "Melendez-Torres, {G. J.} and Xavier Armoiry and Rachel Court and Jacoby Patterson and Alan Kan and Peter Auguste and Jason Madan and Carl Counsell and Olga Ciccarelli and Aileen Clarke",
note = "This work is part of a larger report commissioned by the NIHR HTA Programme as project number ID809. Aileen Clarke and G.J. Melendez-Torres are partly supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care West Midlands at the University Hospitals Birmingham NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, NICE or the Department of Health and Social Care.",
year = "2018",
month = oct,
day = "3",
doi = "10.1186/s12883-018-1162-9",
language = "English",
volume = "18",
journal = "BMC Neurology",
issn = "1471-2377",
publisher = "BioMed Central",
}